Drug Executive Collapses During Oval Office Press Conference
A press conference in the Oval Office was abruptly interrupted when a drug executive fainted while President Donald Trump was announcing a deal to lower prices on obesity medications.
Incident Details
The event involved Trump and representatives from Eli Lilly and Novo Nordisk discussing a new agreement to expand coverage and reduce costs for their obesity drugs, Zepbound and Wegovy. During remarks by David Ricks, CEO of Eli Lilly, he noticed the executive to his right had collapsed.
“Are you okay? Gordon, are you okay?” — David Ricks
The man who collapsed was identified as Gordon Findlay, Novo Nordisk's global brand director. Dr. Mehmet Oz quickly assisted as Findlay fell to his knees and lost consciousness. Health and Human Services Secretary was also present during the incident.
Response and Aftermath
The press was promptly asked to leave the room. Approximately 30 minutes later, the conference resumed with President Trump providing an update on Findlay’s condition.
President Trump gave an update on the executive's health when the conference resumed.
Author's Summary
The unexpected collapse of a drug executive during a high-profile press event highlighted the tense atmosphere around healthcare negotiations in the Oval Office.
More News
- Ex-NFL star Le'Veon Bell issues 8-word message to Antonio Brown after Dubai arrest
- Geno Smith opens up on playing through injury: 'That's how I'm wired'
- Crystal Palace see off AZ Alkmaar in UEFA Conference League | The Express Tribune
- Prince Harry under radar as royal pressure mounts after Andrew’s title loss